The issue figured in the talks between Union Health Minister Jagat Prakash Nadda and his Chinese counterpart Li Bin during their talks here today.
Indian officials had said China had earlier refused to supply more vaccines to India, than what it is being supplied, citing capacity constraints and commitments to other countries.
An Indian delegation earlier visited China to discuss the problem.
Nadda took up the issue with the Chinese leader on the sidelines of Partnership in Population and Development (PPD, an intergovernmental organisation to promote South South cooperation, Indian officials told PTI.
Officials said India at present source 66 million doses of JE vaccine from China and made a case for an additional requirement of 16 million doses for the National Programme for Prevention and Control of Japanese Encephalitis.
Nadda also made a strong case of China importing variety of vaccines from India, which has become a global leader in manufacturing varieties of vaccines.
India has been pressuring China to increase the scope of pharmaceuticals along with IT to offset the trade deficit which touched about USD 38 billion in recent years.
Though India itself is a major producer of vaccines, it is dependent on China for raw materials used in pharmaceuticals.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
